Trial Profile
A Multi-center, Open, Randomized, Three-arm, Parallel-group, Phase IV Study to Compare the Efficacy of Ciclesonide Nasal Spray and Levocetirizine, Alone and in Combination for the Patient With Allergic Rhinitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary) ; Levocetirizine
- Indications Allergic rhinitis
- Focus Therapeutic Use
- Sponsors Handok Inc
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 May 2012 Company added as trial association as reported by ClinicalTrials.gov.
- 09 Sep 2011 New trial record